Angela Garau1, Riccardo Bertini2, Marco Mosca2, Cinzia Bizzarri2, Roberto Anacardio2, Sara Triulzi1, Marcello Allegretti2, Pietro Ghezzi1, Pia Villa1,3
European Cytokine Network, Vol.17, No.1, pp. 35-41, 2006
Abstract The chemokine receptors CXCR1 and CXCR2 present on polymorphonuclear neutrophils (PMN),
bind the chemokine CXC ligand 8 (CXCL8)/interleukin-8 (IL-8), and have a key role in PMN recruitment in
inflammation. Based on the structure of reparixin, a small-molecular-weight allosteric inhibitor of CXCR1, we
designed a dual inhibitor of CXCR1 and CXCR2 with a longer in vivo half-life, DF2156A. This molecule inhibited
human and rat PMN migration in response to CXCR1 and CXCR2 ligands and showed an elimination half-life
following i.v. administration, of 19 hours. In a rat model of cerebral ischemia/reperfusion induced by temporary
(90 min) More >